Search

Search Constraints

You searched for: Author/Creator Arrizabalaga, B.

Search Results

1. 260 CONSIDERING PERCENTAGE OF BLASTS ON THE BASIS OF NON-ERYTHROID COMPARTMENT MIGHT IMPROVE THE CLASSIFICATION AND PROGNOSTICATION OF MDS WITH EXCESS OF BLAST CELLS. Issue 1 (April 2015)

2. 261 ERYTHROLEUKEMIA APPEARS TO BE A CONTINUUM OF MDS WITH ERYTHROID HYPERPLASIA AND SHARES OUTCOME AND CYTOGENETIC FEATURES WITH RAEB-1 WITH ≥50% ERYTHROPOIESIS. Issue 1 (April 2015)

3. Calculating IPSS-R by Enumerating Bone Marrow Blasts from Nonerythroid Cellularity Improves Outcome Prediction in MDS with Erythroid Predominance. (April 2017)

4. Clinical and Biological Significance of Y Chromosome Loss in a Series of 2, 423 Male Patients with MDS and CMML. (April 2017)

5. Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next‐generation sequencing. (17th July 2016)

6. Prognostic Implication of the Percentage of Erythroid Cells in Bone Marrow at Diagnosis in Patients with Myelodysplastic Syndrome. (April 2017)

7. Severe neonatal jaundice due to a de novo glucose‐6‐phosphate dehydrogenase deficient mutation. (23rd December 2015)

8. Sintra-Rev Clinical Trial: Preliminary Analysis of Efficacy and Safety at Week 12 of Treatment in MDS Del(5Q) and Transfusion Independence. (April 2017)

9. The Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts can be Improved by Considering Bone Marrow Blasts from Nonerythroid Cells. (April 2017)